Galmed Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	0	0	0	0	0	2.04	1.09	0.47	0	0	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	87.83%	132.33%	-	-	-	Upgrade
Gross Profit	0	0	0	0	0	2.04	1.09	0.47	0	0	Upgrade
Selling, General & Admin	3.92	4.66	5.66	4.13	4.2	4.44	3.8	3.08	3.25	2.48	Upgrade
Research & Development	3.57	13	27.22	26.08	18.18	8.31	9.65	14.27	7.63	6.66	Upgrade
Operating Expenses	7.49	17.65	32.88	30.21	22.38	12.75	13.45	17.35	10.88	9.14	Upgrade
Operating Income	-7.49	-17.65	-32.88	-30.21	-22.38	-10.72	-12.36	-16.88	-10.88	-9.14	Upgrade
Interest Expense / Income	-0.58	0.22	-0.41	-1.44	-1.92	-0.93	-0.07	-0.04	-0.25	-0.04	Upgrade
Pretax Income	-6.91	-17.87	-32.47	-28.77	-20.46	-9.78	-12.3	-16.85	-10.62	-9.1	Upgrade
Income Tax	0	0	0	0	0	0.08	0	0.11	0	0	Upgrade
Net Income	-6.91	-17.87	-32.47	-28.77	-20.46	-9.86	-12.3	-16.95	-10.62	-9.1	Upgrade
Shares Outstanding (Basic)	3	2	2	1	1	1	1	1	1	1	Upgrade
Shares Outstanding (Diluted)	3	2	2	1	1	1	1	1	1	1	Upgrade
Shares Change	65.23%	2.22%	15.59%	0.79%	16.41%	45.25%	9.78%	2.47%	7.52%	103.64%	Upgrade
EPS (Basic)	-2.50	-10.65	-19.80	-20.25	-14.55	-8.10	-14.70	-22.35	-14.40	-13.20	Upgrade
EPS (Diluted)	-2.50	-10.65	-19.80	-20.25	-14.55	-8.10	-14.70	-22.35	-14.40	-13.20	Upgrade
Free Cash Flow	-6.14	-18.51	-32.9	-26.33	-14.95	-9.11	-12.08	-12.13	-8.63	-10.01	Upgrade
Free Cash Flow Per Share	-2.22	-11.04	-20.07	-18.56	-10.62	-7.54	-14.51	-16.00	-11.67	-14.55	Upgrade
Gross Margin	-	-	-	-	-	100.00%	100.00%	100.00%	-	-	Upgrade
Operating Margin	-	-	-	-	-	-525.76%	-1139.54%	-3614.99%	-	-	Upgrade
Profit Margin	-	-	-	-	-	-483.61%	-1133.55%	-3630.19%	-	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-447.15%	-1113.27%	-2598.07%	-	-	Upgrade
EBITDA	-7.46	-17.62	-32.84	-30.17	-22.34	-10.33	-12.13	-16.71	-10.83	-9.13	Upgrade
EBITDA Margin	-	-	-	-	-	-506.77%	-1117.51%	-3578.80%	-	-	Upgrade
Depreciation & Amortization	0.03	0.04	0.04	0.04	0.04	0.39	0.24	0.17	0.05	0.01	Upgrade
EBIT	-7.49	-17.65	-32.88	-30.21	-22.38	-10.72	-12.36	-16.88	-10.88	-9.14	Upgrade
EBIT Margin	-	-	-	-	-	-525.76%	-1139.54%	-3614.99%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).